Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine dose-escalation pilot study in beta-blocker-treated chronic systolic heart failure
2005-000103-34Phase 2Completed
- Sponsor
- Servier
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ivabradine in heart failure with reduced ejection fraction (HFrEF), sponsored by Servier. Primary endpoints: Heart rate, Systolic blood pressure and 3 more. Started Jun 2005; status: completed.
02
Drugs
ivabradine
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on 2005-000103-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000103-34.